Log in

NASDAQ:NARIInari Medical Insider Trades

$48.44
+0.42 (+0.87 %)
(As of 07/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$47.02
Now: $48.44
$49.42
50-Day Range N/A
52-Week Range
$39.55
Now: $48.44
$54.86
Volume201,400 shs
Average Volume399,019 shs
Market Capitalization$2.27 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Insider Trades

Inari Medical (NASDAQ:NARI) Insider Buying and Selling Activity

Insider Buying and Selling by Quarter


Inari Medical (NASDAQ NARI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/27/2020Andrew HykesInsiderBuy5,650$19.00$107,350.00
5/27/2020Cynthia L LuccheseDirectorBuy28,091$19.00$533,729.00
5/27/2020Mitch C HillCFOBuy9,100$19.00$172,900.00
5/27/2020Presidio Management Group X LlMajor ShareholderBuy97,962$19.00$1,861,278.00
5/27/2020William HoffmanCEOBuy13,095$19.00$248,805.00
(Data available from 1/1/2013 forward)
This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.